(Q71261801)
English
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Em
scientific article published on 01 August 1996
Statements
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group (English)
P Hesketh
R Navari
T Grote
R Gralla
J Hainsworth
M Kris
L Anthony
A Khojasteh
E Tapazoglou
C Benedict